Blake O Langley
Overview
Explore the profile of Blake O Langley including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
48
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Langley B, Rillamas-Sun E, Huang Y, Indorf A, Robles M, Feaster R, et al.
Unknown
. 2025 Jan;
1:e2400062.
PMID: 39758135
Purpose: The increasing use of dietary supplements by patients with cancer and other chronic diseases requires the systematized review of potential interactions between prescription drugs and nutrients from supplements by...
2.
Guedry S, Langley B, Schaefer K, Hanes D
Disabil Rehabil
. 2024 Feb;
46(24):5854-5867.
PMID: 38353245
Purpose: Hypermobility spectrum disorders (HSD) and Ehlers-Danlos syndromes (EDS) are multisystem conditions marked by dysfunctional connective tissue. This feasibility study evaluated a 9-week integrative medicine program in this population. Methods:...
3.
Cohen S, Veleber S, Siman J, Guthrie K, McMillen K, Heit M, et al.
Contemp Clin Trials
. 2023 Jun;
131:107273.
PMID: 37380021
Background: Oxaliplatin is a key chemotherapeutic agent in the treatment of local and metastatic gastrointestinal (GI) malignancies. Dose density and treatment adherence can be limited by chemotherapy-induced peripheral neuropathy (CIPN)....
4.
Langley B, Ryan J, Phipps J, Buttolph L, Bray B, Aslan J, et al.
Trials
. 2022 Oct;
23(1):885.
PMID: 36273173
Background: Xanthohumol (XN), a bioactive flavonoid from Humulus lupulus with anti-inflammatory properties, has potential benefits for patients with Crohn's disease (CD), a type of inflammatory bowel disease. We recently completed...
5.
Guedry S, Langley B, Schaefer K, Hanes D
Disabil Rehabil
. 2022 Oct;
45(21):3549-3559.
PMID: 36222285
Purpose: Hypermobility spectrum disorders (HSD) and Ehlers-Danlos syndromes (EDS) are frequently underdiagnosed, contributing to patient dissatisfaction in the healthcare system. This study evaluated the health service utilization, care, and subjective...
6.
Lee T, Langley B, Noborikawa J, Skye-Babbott A, Booth-LaForce C
J Integr Complement Med
. 2022 Jan;
28(1):36-44.
PMID: 35085022
As the COVID-19 pandemic continues to impact workforces in the United States, the Acupuncture and Telehealth Survey was released to assess the acupuncture profession's use of telehealth and workforce response...
7.
Langley B, Guedry S, Goldenberg J, Hanes D, Beardsley J, Ryan J
J Clin Med
. 2021 Sep;
10(18).
PMID: 34575330
Neutrophil-lymphocyte ratio (NLR) is a biomarker of the systemic inflammatory response. The objective of this systematic scoping review was to examine the literature on NLR and inflammatory bowel disease (IBD)....
8.
Langley B, Ryan J, Hanes D, Phipps J, Stack E, Metz T, et al.
Mol Nutr Food Res
. 2021 Feb;
65(8):e2001170.
PMID: 33629812
Scope: Xanthohumol, a prenylflavonoid from hops, has been extensively studied preclinically but has undergone limited research in human subjects. A triple-masked, placebo-controlled phase I clinical trial was conducted to examine...
9.
Bradley R, Langley B, Ryan J, Phipps J, Hanes D, Stack E, et al.
Trials
. 2020 Oct;
21(1):885.
PMID: 33106168
An amendment to this paper has been published and can be accessed via the original article.
10.
Bradley R, Langley B, Ryan J, Phipps J, Hanes D, Stack E, et al.
Trials
. 2020 Oct;
21(1):835.
PMID: 33028396
Background: Natural products may provide a source for the discovery and development of adjunctive pharmacological interventions to modulate the inflammatory pathways contributing to chronic disease. Xanthohumol, a flavonoid from the...